Gelonghui, April 29丨Tiankang Biotech (002100.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 3.777 billion yuan, down 2.93% year on year; net profit attributable to shareholders of listed companies was 54.638 million yuan, which turned a year-on-year loss into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 56.773 million yuan; basic earnings per share were 0.04 yuan.
天康生物(002100.SZ)：一季度净利润5406.38万元 同比扭亏
Tiankang Biotech (002100.SZ): Net profit of 54.638 million yuan for the first quarter reversed the year-on-year loss
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.